OCEANIC-AF and the inferior efficacy of asundexian compared to apixaban in patients at high risk with atrial fibrillation: Have we come to the end of the road for factor XIa inhibitors?
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2024-10-01
|
| Collection: | American Heart Journal Plus |
| Sujets: | |
| Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S2666602224001071 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|